Former Philips Executive Joins to Accelerate Commercial Strategy and Market Growth
SARASOTA, Fla.–(BUSINESS WIRE)–PaceMate®, a market-leading cardiac remote monitoring and cardiac data management platform, today announced the appointment of JR Finkelmeier as its new Chief Commercial Officer. As Chief Commercial Officer, Finkelmeier will oversee PaceMate’s commercial expansion strategy, focusing on investing in sales, marketing, and customer success initiatives.
Finkelmeier brings over 20 years of experience in healthcare and medical technology—most recently as a Business Leader at Philips, where he led the ECG Solutions Business within the Ambulatory Monitoring and Diagnostics Unit. Before Phillips, he was instrumental in transforming BioTelemetry into a diversified portfolio company ahead of its acquisition by Phillips for $2.8 billion, holding leadership roles spanning product, business, and corporate development.
“JR has demonstrated remarkable success in scaling healthcare and medical technology companies,” said Tripp Higgins, PaceMate CEO. “His track record, vision, and expertise make him the ideal leader to drive the adoption of PaceMate’s cardiac monitoring platform and spearhead our next phase of growth.”
“PaceMate is a leader in cardiac care with its advanced cardiac data platform and clinical service capabilities,” said Finkelmeier. “I’m thrilled to join this dedicated team and accelerate our commercial momentum to expand our impact on cardiac patient lives.”
PaceMate provides expansive cardiac software and clinical service capabilities through PaceMateLIVE™, an end-to-end solution that merges the entire cardiac monitoring workflow from ordering through billing. This platform is supported by advanced algorithms and automatic processing—producing efficiencies across clinical, operational, and financial outcomes.
The news comes on the heels of PaceMate’s recent milestone of completing its 100,000th ambulatory patient transmission.
About PaceMate:
PaceMate is a pioneering force in remote cardiac data management. We’re driven by a mission to modernize digital healthcare and envision a future of connected personalized cardiac care. Since 2015, PaceMate has been simplifying and streamlining device clinic operations into one easy-to-use platform—PaceMateLIVE. As the industry’s only comprehensive cardiac remote monitoring solution, PaceMateLIVE uniquely pairs device and EHR data and prioritizes patient care intelligently. Join us at PaceMate.com to see how together—we never miss a beat.®
Contacts
Haley Chute
haley.chute@pacemate.com
Charlotte, North Carolina--(Newsfile Corp. - December 23, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…
AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…
Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…
Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…
WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…
WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…